(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -37.17%147.97K | -86.74%57.88K | -86.74%57.88K | -0.81%117.15K | 46.66%395.56K | -72.12%235.51K | -66.24%436.68K | -66.24%436.68K | -72.19%118.11K | -53.53%269.71K |
-Cash and cash equivalents | -26.83%147.97K | -85.65%57.88K | -85.65%57.88K | 77.43%117.15K | 52.47%362.26K | -72.20%202.21K | -62.67%403.38K | -62.67%403.38K | -70.86%66.03K | -18.80%237.59K |
Total current assets | -36.72%162.2K | -81.90%103.06K | -81.90%103.06K | -38.44%156.63K | 2.16%448.43K | -76.09%256.31K | -66.13%569.5K | -66.13%569.5K | -47.98%254.43K | -39.35%438.95K |
Non current assets | ||||||||||
-Accumulated depreciation | ---- | 15.36%-135.89K | 15.36%-135.89K | 4.96%-166.62K | 2.57%-164.61K | -30.48%-162.6K | -2.78%-160.55K | -2.78%-160.55K | -16.95%-175.31K | -17.70%-168.94K |
-Other intangible assets | -32.28%219.78K | -32.28%219.78K | -32.28%219.78K | -46.43%526.32K | -74.95%526.32K | -85.32%324.52K | -85.79%324.52K | -85.79%324.52K | -51.86%982.54K | -4.26%2.1M |
Regulatory assets | -36.12%12.15K | 39.93%39.65K | 39.93%39.65K | 9.67%30.47K | -36.05%39.53K | -35.68%19.02K | -66.22%28.33K | -66.22%28.33K | 125.85%27.78K | -18.72%61.81K |
Total assets | -36.12%12.15K | 39.93%39.65K | 39.93%39.65K | 9.67%30.47K | -36.05%39.53K | -35.68%19.02K | -66.22%28.33K | -66.22%28.33K | 125.85%27.78K | 0.93%61.81K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
-accounts payable | 21.25%490.62K | -14.85%375.46K | -14.85%375.46K | 72.93%441.4K | 87.01%514.53K | 67.26%404.62K | 43.04%440.96K | 43.04%440.96K | 17.94%255.25K | 47.86%275.14K |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Current accrued expenses | 1.62%74.37K | 49.17%109.51K | 49.17%109.51K | -21.74%76.46K | 205.84%76.46K | 17.08%73.18K | -30.72%73.41K | -30.72%73.41K | -27.37%97.71K | -22.01%25K |
Current provisions | -53.20%86.53K | -53.20%86.53K | -53.20%86.53K | 0.00%184.91K | 0.00%184.91K | -4.94%184.91K | -7.96%184.91K | -7.96%184.91K | -7.96%184.91K | -8.12%184.91K |
Current deferred liabilities | ---- | --0 | --0 | --0 | --0 | --69.57K | --136.39K | --136.39K | ---- | ---- |
Current liabilities | -11.03%651.52K | -31.61%571.5K | -31.61%571.5K | 30.66%702.76K | 59.96%775.9K | 46.77%732.28K | 35.85%835.66K | 35.85%835.66K | -2.44%537.86K | 15.65%485.05K |
Non current liabilities | ||||||||||
Non current accrued expenses | ---- | --0 | --0 | -65.59%10.05K | -66.09%12.06K | -65.83%14.08K | -66.64%16.12K | -66.64%16.12K | -46.52%29.21K | -41.66%35.58K |
Total non current liabilities | -11.03%651.52K | -31.61%571.5K | -31.61%571.5K | 30.66%702.76K | 59.96%775.9K | 46.77%732.28K | 35.85%835.66K | 35.85%835.66K | -2.53%537.86K | 15.65%485.05K |
Shareholders'equity | ||||||||||
Share capital | 0.51%48.67M | 0.50%48.66M | 0.50%48.66M | 0.73%48.66M | 0.73%48.66M | 0.24%48.43M | 0.36%48.42M | 0.36%48.42M | 2.82%48.31M | 2.85%48.31M |
-common stock | 0.51%48.67M | 0.50%48.66M | 0.50%48.66M | 0.73%48.66M | 0.73%48.66M | 0.24%48.43M | 0.36%48.42M | 0.36%48.42M | 2.82%48.31M | 2.85%48.31M |
Additional paid-in capital | 1.38%26.72M | 1.56%26.72M | 1.56%26.72M | 3.05%26.42M | 7.79%26.42M | 8.08%26.36M | 8.35%26.31M | 8.35%26.31M | 7.15%25.63M | 3.22%24.51M |
Other equity interest | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1 | ---- |
Total equity | -40.01%162.2K | -82.40%103.06K | -82.40%103.06K | -41.23%166.69K | -2.96%460.5K | -75.71%270.38K | -66.14%585.61K | -66.14%585.61K | -47.83%283.64K | -39.53%474.53K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.